Data to support US sales roll out and EU + UK regulatory submissions 

• Interim results from a new Remplir™ study demonstrated a compelling overalltreatment success rate of 81.1%following nerve repair procedures.
• Real World Evidence (RWE) patient data collected in the study confirms Orthocell's nerve repair product, Remplir, as the...